THMO (ThermoGenesis Holdings) Days Payable: 57.54 (As of Mar. 2024)


THMO ThermoGenesis Holdings Inc THMO
16 GF Score
Price $0.00
View Full Analysis

What is ThermoGenesis Holdings Days Payable?

ThermoGenesis Holdings THMO 16 Days Payable is 57.54 as of Mar. 2024. GuruFocus rates THMO with a GF Score™ of 16/100.

ThermoGenesis Holdings's average Accounts Payable for the three months ended in Mar. 2024 was $0.97 Mil. ThermoGenesis Holdings's Cost of Goods Sold for the three months ended in Mar. 2024 was $1.54 Mil. Hence, ThermoGenesis Holdings's Days Payable for the three months ended in Mar. 2024 was 57.54.

The historical rank and industry rank for ThermoGenesis Holdings's Days Payable or its related term are showing as below:

THMO's Days Payable is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 68.07
* Ranked among companies with meaningful Days Payable only.

ThermoGenesis Holdings's Days Payable increased from Mar. 2023 (54.55) to Mar. 2024 (57.54). It may suggest that ThermoGenesis Holdings delayed paying its suppliers.

ThermoGenesis Holdings Days Payable Historical Data

* Premium members only.

The historical data trend for ThermoGenesis Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ThermoGenesis Holdings Days Payable Chart

ThermoGenesis Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 96.08 60.50 83.24 49.31 42.94

ThermoGenesis Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.55 36.47 27.87 28.73 57.54

THMO vs MSIU, MOTS, ABT: Days Payable Comparison

For the Medical Devices subindustry, ThermoGenesis Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ThermoGenesis Holdings Days Payable vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ThermoGenesis Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where ThermoGenesis Holdings's Days Payable falls into.


THMO
16GF Score
ThermoGenesis Holdings Inc THMO
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ThermoGenesis Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

ThermoGenesis Holdings's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (0.82 + 0.948) / 2 ) / 7.514*365
=0.884 / 7.514*365
=42.94

ThermoGenesis Holdings's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (0.948 + 0.988) / 2 ) / 1.535*365 / 4
=0.968 / 1.535*365 / 4
=57.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 57.54 mean?
ThermoGenesis Holdings (THMO) has a Days Payable of 57.54 as of Mar. 2024. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on ThermoGenesis Holdings and its competitors.
Is ThermoGenesis Holdings' Days Payable too high?
ThermoGenesis Holdings' current Days Payable is 57.54. The Medical Devices & Instruments industry median Days Payable is 68.07. ThermoGenesis Holdings' value of 57.54 is 15.5% below this industry median. Overall, ThermoGenesis Holdings has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does ThermoGenesis Holdings' Days Payable compare to MSIU and MOTS?
ThermoGenesis Holdings' Days Payable of 57.54 can be compared against companies in the Medical Devices & Instruments industry. The industry median Days Payable is 68.07. ThermoGenesis Holdings' value of 57.54 is 15.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ThermoGenesis Holdings's current Days Payable of 57.54 is 15.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on ThermoGenesis Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ThermoGenesis Holdings's current Days Payable is 57.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ThermoGenesis Holdings stock overvalued right now?
ThermoGenesis Holdings (THMO) has a current Days Payable of 57.54. The current Days Payable is 57.54 and 15.5% below the Medical Devices & Instruments industry median of 68.07. ThermoGenesis Holdings' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For ThermoGenesis Holdings (THMO), the current Days Payable is 57.54 as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ThermoGenesis Holdings Business Description

Address 2711 Citrus Road, Rancho Cordova, CA, USA, 95742
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.
16GF Score

Get the complete analysis for THMO

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price